Hospital Costa del Sol

Hospital Costa del Sol is active in cardiology studies focused on cardiovascular diseases, including acute pulmonary embolism, hypertension, atherosclerotic cardiovascular disease, and idiopathic dilated cardiomyopathy. These trials are mainly aimed at testing new treatments, improving prevention strategies, and evaluating how well existing therapies protect patients at higher risk.

• New approaches for pulmonary hypertension and pulmonary arterial hypertension
• Prevention of major cardiovascular events and thrombotic complications
• Treatment studies in heart failure and dilated cardiomyopathy

The site also contributes to research on better symptom control and safer treatment options for complex heart and circulation disorders.

A major part of the research portfolio at Hospital Costa del Sol covers hematologic malignancies such as chronic lymphocytic leukemia, small lymphocytic lymphoma, multiple myeloma, mantle cell lymphoma, follicular lymphoma, and Hodgkin lymphoma. The trials are designed to compare new therapy combinations, improve remission rates, and support longer disease control.

• Studies in CLL and SLL exploring targeted treatment options
• Research in multiple myeloma and myelofibrosis seeking better disease control
• Trials in lymphomas evaluating new combinations for response and progression outcomes

Overall, this area reflects a strong focus on advancing personalized cancer care for blood-related cancers.

The site is also involved in studies on respiratory tract diseases and infectious diseases, including asthma, chronic obstructive pulmonary disease, COVID-19, HIV, and several bacterial infections. These trials aim to improve treatment effectiveness, reduce complications, and assess safer ways to manage both acute and chronic conditions.

• Therapy studies for moderate-to-severe asthma and COPD
• Clinical research in COVID-19 and other viral infections
• Antibiotic-focused trials for bacteremia and urinary tract infections

This work supports better management of common respiratory illness and serious infections across adult patient groups.

Clinical trials at the site also address digestive system diseases, nutritional and metabolic diseases, and kidney-related conditions. Main areas include acute pancreatitis, recurrent pancreatitis, irritable bowel syndrome, type 2 diabetes, and chronic kidney disease. The purpose of these studies is to test better supportive care, prevent recurrence, and improve long-term disease control.

• Research on safer and more effective care for acute pancreatitis
• Trials aimed at preventing recurrence of pancreatitis and related complications
• Studies in chronic kidney disease and diabetes looking at improved treatment benefit

These investigations help expand treatment options for patients with complex digestive and metabolic disorders.

Beyond blood cancers, the research program includes solid tumor studies in breast cancer, colorectal cancer, lung cancer, urothelial carcinoma, and skin cancer. Trials at Hospital Costa del Sol are focused on testing new combinations, improving response to treatment, and supporting recovery after surgery or prior therapy.

• Studies in HER2-positive breast cancer and advanced breast disease
• Trials in lung cancer and colorectal cancer assessing treatment effectiveness
• Research in skin, urinary tract, and other solid tumors exploring better care strategies

This area shows a broad commitment to improving cancer treatment choices and patient outcomes across several tumor types.

The site participates in research on eye diseases, skin and connective tissue diseases, and surgical infections. Key conditions include corneal trophic ulcers, basal cell cancer, and infections linked to implanted orthopedic material. These trials are intended to evaluate new reconstructive approaches, assess healing support, and improve infection management after surgery.

• Studies testing novel options for severe corneal disease
• Research on reconstructive skin surgery in cancer care
• Trials for implant-associated infections and antibiotic treatment strategies

These studies reflect a practical focus on restoring function and reducing complications in difficult-to-treat conditions.